Assessing Pharvaris (PHVS) Valuation After Recent Share Price Volatility And DCF Upside Gap [Yahoo! Finance]
Pharvaris N.V. - Ordinary Shares (PHVS)
Company Research
Source: Yahoo! Finance
Pharvaris (PHVS) has recently drawn investor attention after shares closed at $25.09, with the stock showing a negative 1 day move, a small decline over the past week, and gains over the past month and past 3 months. See our latest analysis for Pharvaris. Looking beyond the recent pullback, Pharvaris has a 30 day share price return of 4.15%, a 90 day share price return of 18.80%, and a 1 year total shareholder return of 36.66%. This suggests momentum has been building despite a negative year to date share price move of 5.25% and some recent volatility. The 3 year total shareholder return of 144.78% also highlights how sentiment around its late stage rare disease pipeline has shifted over a longer horizon. If Pharvaris has caught your eye, it can be helpful to see what else is moving in the sector, starting with healthcare stocks as a wider set of healthcare ideas. With Pharvaris still loss making, trading at $25.09, and sitting at a large discount to some valuation models and
Show less
Read more
Impact Snapshot
Event Time:
PHVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PHVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PHVS alerts
High impacting Pharvaris N.V. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
PHVS
News
- Pharvaris (NASDAQ:PHVS) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=PHVS&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</aMarketBeat
- Pharvaris Outlines 2026 Strategic PrioritiesGlobeNewswire
- Pharvaris (NASDAQ:PHVS) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=PHVS&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> MarketBeat
- What Does Wall Street Think About Pharvaris N.V. (PHVS)? [Yahoo! Finance]Yahoo! Finance
- Pharvaris (NASDAQ:PHVS) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=PHVS&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</aMarketBeat
PHVS
Earnings
- 11/12/25 - Beat
PHVS
Sec Filings
- 1/12/26 - Form 6-K
- 1/2/26 - Form 144
- 12/4/25 - Form 144
- PHVS's page on the SEC website